Luteolin monohydrate
Based on 90 publication(s) in Google Scholar
Luteolin (monohydrate) is the monohydrate of Luteolin. Luteolin (Luteoline), a flavonoid, is also a potent Nrf2 inhibitor. Luteolin has anti-inflammatory and anticancer properties, induces apoptosis and cell cycle arrest in multiple human cancer cell lines, including non-small lung cancer cells, and inhibits cell metastasis and angiogenesis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.13%
- CAS No.: 6113-16-2
- Formule: C15H12O7
- Masse moléculaire:304.25
-
Stockage:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications Citing Use of MedChemExpress (MCE) Luteolin monohydrate
More- Adv Sci (Weinh). 2026 Apr;13(19):e16106. [Abstract]
- Adv Sci (Weinh). 2025 Nov 21:e08472. [Abstract]
- Theranostics. 2024 Sep 3;14(14):5551-5570. [Abstract]
- J Hazard Mater. 2026 Mar 15:506:141417. [Abstract]
- Food Chem. 2025 Dec 30:497:146992. [Abstract]
- Food Chem. 2025 May 31:489:144992. [Abstract]
- Food Chem. 2023 Mar 30;405(Pt A):134807. [Abstract]
- Cell Death Dis. 2025 Oct 7;16(1):714. [Abstract]
- Phytomedicine. 2025 Dec 24:150:157740. [Abstract]
- Phytomedicine. 2025 Nov 22:150:157586. [Abstract]
- Phytomedicine. 2025 Oct:146:157117. [Abstract]
- Phytomedicine. 2025 May 27:143:156911. [Abstract]
- Phytomedicine. 2025 May:140:156484. [Abstract]
- Phytomedicine. 2024 May 10:130:155611. [Abstract]
- Free Radic Biol Med. 2023 Nov 1:208:530-544. [Abstract]
- Food Res Int. 2025 Dec;222(Pt 1):117620. [Abstract]
- Biomed Pharmacother. 2024 Jul:176:116847. [Abstract]
- Antioxidants (Basel). 2026 May 29;15(6):688. [Abstract]
- Int J Nanomedicine. 2025 Dec 28:20:15883-15899. [Abstract]
- Phytother Res. 2023 Nov;37(11):5315-5327. [Abstract]
- Phytother Res. 2021 Nov;35(11):6228-6240. [Abstract]
- Ind Crops Prod. 2026 Jan 22;241:122697.
- Ind Crops Prod. 2025 Dec 11;239:122458.
- J Agric Food Chem. 2022 May 25;70(20):6134-6144. [Abstract]
- Cancer Cell Int. 2023 Sep 25;23(1):213. [Abstract]
- Chin Med. 2024 Mar 18;19(1):48. [Abstract]
- Am J Chin Med. 2025 Aug 30:1-32. [Abstract]
- J Ethnopharmacol. 2026 May 23:363:121393. [Abstract]
- Chem Biol Interact. 2025 Sep 5:111738. [Abstract]
- J Ethnopharmacol. 2024 Nov 25:119157. [Abstract]
- J Ethnopharmacol. 2024 Jul 11:118576. [Abstract]
- Food Funct. 2024 Feb 19;15(4):2144-2153. [Abstract]
- J Ethnopharmacol. 2023 Dec 5:317:116773. [Abstract]
- Int J Mol Sci. 2025 Jun 15;26(12):5739. [Abstract]
- Biomolecules. 2025 Jun 16;15(6):873. [Abstract]
- Front Pharmacol. 2023 Oct 31:14:1255069. [Abstract]
- Pharmaceuticals (Basel). 2023 Jul 7;16(7):975. [Abstract]
- Front Pharmacol. 2021 Apr 15:12:663551. [Abstract]
- Front Pharmacol. 2018 Jun 13:9:620. [Abstract]
- Eur J Pharmacol. 2025 Dec 5:1008:178355. [Abstract]
- Eur J Pharmacol. 2025 Oct 5:1004:177984. [Abstract]
- Bioorg Chem. 2024 Jun:147:107412. [Abstract]
- Cancers (Basel). 2023 Jul 24;15(14):3741. [Abstract]
- Cancers (Basel). 2023 Jan 16;15(2):548. [Abstract]
- Poult Sci. 2026 Jan 12;105(3):106426. [Abstract]
- J Inflamm Res. 2021 Dec 16;14:6939-6958. [Abstract]
- Pestic Biochem Physiol. 2025 Dec:215:106655. [Abstract]
- J Chromatogr A. 2022 Aug 16:1677:463329. [Abstract]
- Sci Rep. 2025 Nov 26;15(1):42044. [Abstract]
- Fish Shellfish Immunol. 2025 Aug 6:166:110633. [Abstract]
- Sci Rep. 2025 Jul 7;15(1):24311. [Abstract]
- Sci Rep. 2025 Apr 11;15(1):12398. [Abstract]
- Mol Divers. 2025 Jan 16. [Abstract]
- Eur J Med Res. 2026 Mar 9. [Abstract]
- Biochim Biophys Acta Mol Cell Biol Lipids. 2025 May 16:159635. [Abstract]
- Comput Biol Chem. 2025 Oct 15;120(Pt 2):108721. [Abstract]
- Naunyn Schmiedebergs Arch Pharmacol. 2025 Oct 29. [Abstract]
- Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6837-6850. [Abstract]
- Am J Physiol Endocrinol Metab. 2021 Jun 1;320(6):E1085-E1092. [Abstract]
- Ren Fail. 2023 Dec;45(1):2184654. [Abstract]
- Discov Oncol. 2025 Aug 8;16(1):1506. [Abstract]
- Infect Drug Resist. 2025 Jul 3:18:3257-3277. [Abstract]
- Shock. 2023 Aug 1;60(2):306-314. [Abstract]
- Int J Biochem Cell Biol. 2026 May:194:106909. [Abstract]
- Vet Microbiol. 2026 May:316:110992. [Abstract]
- BMC Pharmacol Toxicol. 2024 Jul 12;25(1):40. [Abstract]
- Vet Microbiol. 2022 Oct:273:109527. [Abstract]
- Toxicol In Vitro. 2020 Jun;65:104825. [Abstract]
- Pharm Dev Technol. 2025 Nov;30(10):1543-1556. [Abstract]
- Biomed Res Int. 2022 Jul 23:2022:8080679. [Abstract]
- Cancer Rep (Hoboken). 2025 May;8(5):e70169. [Abstract]
- Biol Pharm Bull. 2025;48(10):1514-1525. [Abstract]
- Biol Pharm Bull. 2022;45(8):1116-1123. [Abstract]
- Lett Drug Des Discov. 2026 Jan 10.
- Nat Prod Commun. 2025 Dec 17.
- Int Ophthalmol. 2025 Nov 19;45(1):494. [Abstract]
- Medicine. 2023 Oct 13;102(41):e35384. [Abstract]
- Int J Clin Exp Pathol. 2022 May 15;15(5):206-214. [Abstract]
- Res Sq. 2026 Feb 24.
- SSRN. 2026 Jan 15.
- bioRxiv. 2025 Oct 3.
- SSRN. 2025 Jul 8.
- Res Sq. 2025 Jul 11.
- Research Square Preprint. 2023 Sep 18.
- Phytomed Plus. 2023 Sep 1, 100483.
- Oxid Med Cell Longev. 2023 Feb 10:2023:6726654. [Abstract]
- Contrast Media Mol Imaging. 2022 Aug 18:2022:3517020. [Abstract]
- Oxid Med Cell Longev. 2022 Apr 25;2022:3846217. [Abstract]
- Evid Based Complement Alternat Med. 2021 Nov 27:2021:7765658. [Abstract]
- Evid Based Complement Alternat Med. 2021 Aug 26:2021:7169211. [Abstract]
-
Bio/Physico-chemical Assay
-
Cell Proliferation/Viability Assay
-
IF
-
Histological Imaging/Staining
-
WB
Voir tous les produits spécifiques à Isoform Endogenous Metabolite
More
Activité biologique
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 6113-16-2
-
Appearance Solid
-
Masse moléculaire 304.25
-
Formule C15H12O7
-
Color Light yellow to yellow
-
SMILES
O=C1C=C(C2=CC(O)=C(O)C=C2)OC3=C1C(O)=CC(O)=C3.O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (90)
-
Journal Impact Factor
-
Most Recent
-
Adv Sci (Weinh)
GALNT10 Affects O-Glycosylation of IGFBP7 to Promote Tumor Vascular Remodeling and Metastasis of Ovarian Cancer. [Abstract]2026 Apr;13(19):e16106. PMID: 41637621 -
Adv Sci (Weinh)
Targeted Inhibition of CD74+ Macrophages by Luteolin via CEBPB/P65 Signaling Ameliorates Osteoarthritis Progression. [Abstract]2025 Nov 21:e08472. PMID: 41268703 -
Theranostics
The m6A reader YTHDC2 promotes the pathophysiology of temporal lobe epilepsy by modulating SLC7A11-dependent glutamate dysregulation in astrocytes. [Abstract]2024 Sep 3;14(14):5551-5570. PMID: 39310099
Luteolin monohydrate purchased from MedChemExpress. Usage Cited in: Theranostics. 2024 Sep 3;14(14):5551-5570. [Abstract]
Luteolin (25 mg/kg, i.p., daily). Immunofluorescence analysis of astrocytes co-stained with NRF2 in the CA1 region of mice across different groups. Treatment with Luteolin, an NRF2 inhibitor, results in a reduction of NRF2 expression.
-
J Hazard Mater
Ammonia-induced exosomal miRNA disrupts autophagy and promotes lung injury: Therapeutic potential of natural compounds. [Abstract]2026 Mar 15:506:141417. PMID: 41775203 -
Food Chem
Effects of sun drying combined with baking processes on the flavor quality of Chongqing Tuocha raw tea. [Abstract]2025 Dec 30:497:146992. PMID: 41285060 -
Food Chem
Flavonoid-mediated metabolic underpinning quality variation in red bud-sport pear mutants. [Abstract]2025 May 31:489:144992. PMID: 40466530 -
Food Chem
Discovery of novel ascorbic acid derivatives and other metabolites in fruit of Rosa roxburghii Tratt through untargeted metabolomics and feature-based molecular networking. [Abstract]2023 Mar 30;405(Pt A):134807. PMID: 36370576 -
Cell Death Dis
Mechanisms and targeted prevention of abnormal ductular reaction caused by a low concentration of Benzo(a)pyrene. [Abstract]2025 Oct 7;16(1):714. PMID: 41057340
Luteolin monohydrate purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2025 Oct 7;16(1):714. [Abstract]
Luteolin (10 mg/kg; p.o.; daily for 4 weeks). Biochemical analysis of blood in NC, luteolin, B[a]P and B[a]P + luteolin groups.
-
Phytomedicine
Bruceantin inhibits the c-Myc/RL27A axis to suppress tumor progression in hepatocellular carcinoma. [Abstract]2025 Dec 24:150:157740. PMID: 41477978 -
Phytomedicine
Study on the anti-liver cirrhosis of Fuzheng Huayu tablet : Targeting macrophage PPARα axis-fatty acid metabolic. [Abstract]2025 Nov 22:150:157586. PMID: 41380414 -
Phytomedicine
Luteolin Induces GPX4-dependent Ferroptosis and Enhances Immune Activation in Colon Cancer. [Abstract]2025 Oct:146:157117. PMID: 40812220
Luteolin monohydrate purchased from MedChemExpress. Usage Cited in: Phytomedicine. 2025 Oct:146:157117. [Abstract]
Luteolin (0-100 μM; 48 h). Cell viability of MC38 and CT26 cells treated with varying concentrations of luteolin is assessed using the CCK-8 assay.
-
Phytomedicine
CBX5 loss drives Pl3Kδ inhibitor resistance in mantle cell lymphoma and propolis restores sensitivity by inducing CBX5-mediated ferroptosis. [Abstract]2025 May 27:143:156911. PMID: 40466505 -
Phytomedicine
Fangchinoline suppresses nasopharyngeal carcinoma progression by inhibiting SQLE to regulate the PI3K/AKT pathway dysregulation. [Abstract]2025 May:140:156484. PMID: 40090046 -
Phytomedicine
Effect of luteolin on glioblastoma's immune microenvironment and tumor growth suppression. [Abstract]2024 May 10:130:155611. PMID: 38776737
Luteolin monohydrate purchased from MedChemExpress. Usage Cited in: Phytomedicine. 2024 May 10:130:155611. [Abstract]
Luteolin (60-120 μM; injected into the basal ganglia of the mice using a microsyringe; a total injection time of no less than 5 min). Hematoxylin and eosin staining of intracranial tumor plantation shows the tumor size in the coronal location of four groups.
-
Free Radic Biol Med
Luteolin exhibits synergistic therapeutic efficacy with erastin to induce ferroptosis in colon cancer cells through the HIC1-mediated inhibition of GPX4 expression. [Abstract]2023 Nov 1:208:530-544. PMID: 37717793 -
Food Res Int
Glycyrrhiza uralensis Fisch: A novel source of analgesic activity through NaV1.8 sodium channel modulation. [Abstract]2025 Dec;222(Pt 1):117620. PMID: 41267240 -
Biomed Pharmacother
Decrease in GPSM2 mediated by the natural product luteolin contributes to colon adenocarcinoma treatment and increases the sensitivity to fluorouracil. [Abstract]2024 Jul:176:116847. PMID: 38823277 -
Antioxidants (Basel)
Bioactive Extracts and Constituents from Taraxacum mongolicum: Antioxidant, Anti-Inflammatory, Enzyme-Inhibitory, and Molecular Docking Studies. [Abstract]2026 May 29;15(6):688. PMID: 42351994 -
Int J Nanomedicine
Targeted Sustained-Release Therapy for Vulnerable Atherosclerotic Plaques Using Luteolin-Loaded Nanoparticles. [Abstract]2025 Dec 28:20:15883-15899. PMID: 41488864 -
Phytother Res
2023 Nov;37(11):5315-5327. PMID: 37469042 -
Phytother Res
Luteolin combined with low-dose paclitaxel synergistically inhibits epithelial-mesenchymal transition and induces cell apoptosis on esophageal carcinoma in vitro and in vivo. [Abstract]2021 Nov;35(11):6228-6240. PMID: 34494324 -
-
-
J Agric Food Chem
2022 May 25;70(20):6134-6144. PMID: 35544338 -
Cancer Cell Int
Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma. [Abstract]2023 Sep 25;23(1):213. PMID: 37749554 -
Chin Med
The combination of Schisandrin C and Luteolin synergistically attenuates hepatitis B virus infection via repressing HBV replication and promoting cGAS-STING pathway activation in macrophages. [Abstract]2024 Mar 18;19(1):48. PMID: 38500179 -
Am J Chin Med
Identification of Flavonoid Compounds in Treating Alzheimer's Disease Based on Network Medicine Framework Strategy. [Abstract]2025 Aug 30:1-32. PMID: 40884807 -
J Ethnopharmacol
Dandelion (Taraxacum mongolicum Hand. -Mazz.) extract inhibits triple-negative breast cancer by inducing ferroptosis via NCOA4-mediated ferritinophagy. [Abstract]2026 May 23:363:121393. PMID: 41707813 -
Chem Biol Interact
Involvement of ductal reaction in Di-(2-ethylhexyl)-phthalate-caused hepatic fibrosis: Molecular mechanisms and potential intervention strategies. [Abstract]2025 Sep 5:111738. PMID: 40915524 -
J Ethnopharmacol
Luteolin modulates macrophage phenotypic switching via the AMPK-PPARγ pathway to alleviate ulcerative colitis in mice. [Abstract]2024 Nov 25:119157. PMID: 39603400 -
J Ethnopharmacol
Integrating UHPLC-Q-TOF-MS/MS, network pharmacology, bioinformatics and experimental validation to uncover the anti-cancer mechanisms of TiaoPi AnChang decoction in colorectal cancer. [Abstract]2024 Jul 11:118576. PMID: 39002822 -
Food Funct
A Capsicum annuum L. seed extract exerts anti-neuroexcitotoxicity in HT22 hippocampal neurons. [Abstract]2024 Feb 19;15(4):2144-2153. PMID: 38305768 -
J Ethnopharmacol
Research into the anti-pulmonary fibrosis mechanism of Renshen Pingfei formula based on network pharmacology, metabolomics, and verification of AMPK/PPAR-γ pathway of active ingredients. [Abstract]2023 Dec 5:317:116773. PMID: 37308028 -
Int J Mol Sci
Luteolin Potentially Alleviates Methamphetamine Withdrawal-Induced Negative Emotions and Cognitive Deficits Through the AKT/FOXO1/HO-1 Signaling Pathway in the Prefrontal Cortex and Caudate Putamen. [Abstract]2025 Jun 15;26(12):5739. PMID: 40565203 -
Biomolecules
Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration. [Abstract]2025 Jun 16;15(6):873. PMID: 40563513 -
Front Pharmacol
2023 Oct 31:14:1255069. PMID: 38026984 -
Pharmaceuticals (Basel)
Luteolin Protects Pancreatic β Cells against Apoptosis through Regulation of Autophagy and ROS Clearance. [Abstract]2023 Jul 7;16(7):975. PMID: 37513887 -
Front Pharmacol
Luteolin Ameliorates Experimental Pulmonary Arterial Hypertension via Suppressing Hippo-YAP/PI3K/AKT Signaling Pathway. [Abstract]2021 Apr 15:12:663551. PMID: 33935785 -
Front Pharmacol
Exploring the Therapeutic Mechanism of Desmodium styracifolium on Oxalate Crystal-Induced Kidney Injuries Using Comprehensive Approaches Based on Proteomics and Network Pharmacology. [Abstract]2018 Jun 13:9:620. PMID: 29950996
Luteolin monohydrate purchased from MedChemExpress. Usage Cited in: Front Pharmacol. 2018 Jun 13:9:620. [Abstract]
Effects of Luteolin on the level of CTSD and p-CDK2 in HK-2 cells. The western blotting results of CTSD and p-CDK2 in the NaOx-stimulated HK-2 cells treated by Luteolin.
-
Eur J Pharmacol
NF-κB/TOM6/PINK1-mediated mitophagy attenuates vascular calcification: Luteolin as a therapeutic modulator. [Abstract]2025 Dec 5:1008:178355. PMID: 41232657 -
Eur J Pharmacol
Luteolin targets peroxiredoxin 2 to augment T-cell-mediated cytotoxicity and suppress lung adenocarcinoma progression. [Abstract]2025 Oct 5:1004:177984. PMID: 40712879 -
Bioorg Chem
Identification of FTY720 and COH29 as novel topoisomerase I catalytic inhibitors by experimental and computational studies. [Abstract]2024 Jun:147:107412. PMID: 38696845 -
Cancers (Basel)
Optimization of a Luteolin-Loaded TPGS/Poloxamer 407 Nanomicelle: The Effects of Copolymers, Hydration Temperature and Duration, and Freezing Temperature on Encapsulation Efficiency, Particle Size, and Solubility. [Abstract]2023 Jul 24;15(14):3741. PMID: 37509402 -
Cancers (Basel)
Synergistic Combination of Luteolin and Asiatic Acid on Cervical Cancer In Vitro and In Vivo. [Abstract]2023 Jan 16;15(2):548. PMID: 36672499 -
Poult Sci
Targeting TatD nuclease and the MAPK Pathway: Luteolin multifaceted approach against Mycoplasma gallisepticum infection. [Abstract]2026 Jan 12;105(3):106426. PMID: 41548475 -
J Inflamm Res
Computational Systems Pharmacology, Molecular Docking and Experiments Reveal the Protective Mechanism of Li-Da-Qian Mixture in the Treatment of Glomerulonephritis. [Abstract]2021 Dec 16;14:6939-6958. PMID: 34949932 -
Pestic Biochem Physiol
Mechanistic insights into chlorogenic acid and caffeic acid as novel juvenile hormone antagonists. [Abstract]2025 Dec:215:106655. PMID: 41162045 -
J Chromatogr A
Quality by Design in optimizing the extraction of (poly)phenolic compounds from Vaccinium myrtillus berries. [Abstract]2022 Aug 16:1677:463329. PMID: 35863094 -
Sci Rep
The mechanism of luteolin suppressing pancreatic cancer (PC) via cyclin B1 (CCNB1)-mediated signalling. [Abstract]2025 Nov 26;15(1):42044. PMID: 41298459 -
Fish Shellfish Immunol
Emodin enhances host antiviral immunity against Micropterus salmoides rhabdovirus by activating RLR signaling in largemouth bass. [Abstract]2025 Aug 6:166:110633. PMID: 40769268 -
Sci Rep
2025 Jul 7;15(1):24311. PMID: 40624153 -
Sci Rep
Study on the regulatory mechanism of luteolin inhibiting WDR72 on the proliferation and metastasis of non small cell lung cancer. [Abstract]2025 Apr 11;15(1):12398. PMID: 40216870 -
Mol Divers
Investigating the molecular mechanism of epimedium herb in treating rheumatoid arthritis through network pharmacology, molecular docking, and experimental validation. [Abstract]2025 Jan 16. PMID: 39821498 -
Eur J Med Res
Integrative analysis reveals luteolin's molecular targets and mechanisms in pancreatic cancer treatment. [Abstract]2026 Mar 9. PMID: 41803987 -
Biochim Biophys Acta Mol Cell Biol Lipids
Lauric acid ameliorates excessive linoleic acid induced macrophage inflammatory response and oxidative stress in large yellow croaker (Larimichthys crocea). [Abstract]2025 May 16:159635. PMID: 40383251 -
Comput Biol Chem
Integrated strategy of serum metabolomics, network pharmacology and experimental validation on revealing the bioactive metabolites and mechanism of Lycium ruthenicum Murr. against colorectal carcinoma. [Abstract]2025 Oct 15;120(Pt 2):108721. PMID: 41105991 -
Naunyn Schmiedebergs Arch Pharmacol
Phytochemical characterization and multi-target mechanism of Gleditsia sinensis Fructus in lung adenocarcinoma treatment. [Abstract]2025 Oct 29. PMID: 41160117 -
Naunyn Schmiedebergs Arch Pharmacol
Mechanism of Sophorae Flavescentis Radix against ovarian cancer via new pharmacology, molecular docking, and experimental verification. [Abstract]2024 Sep;397(9):6837-6850. PMID: 38561549 -
Am J Physiol Endocrinol Metab
Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress. [Abstract]2021 Jun 1;320(6):E1085-E1092. PMID: 33900851 -
Ren Fail
Forecast and verification of the active compounds and latent targets of Guyuan decoction in treating frequently relapsing nephrotic syndrome based on network pharmacology. [Abstract]2023 Dec;45(1):2184654. PMID: 36866869 -
Discov Oncol
Identification of potential molecular targets of luteolin in the treatment of hepatocellular carcinoma based on network pharmacology and transcriptome sequencing technology. [Abstract]2025 Aug 8;16(1):1506. PMID: 40778996 -
Infect Drug Resist
Investigating the Therapeutic Mechanisms of Honeysuckle (China) in Sepsis Through Network Pharmacology and Experimental Validation. [Abstract]2025 Jul 3:18:3257-3277. PMID: 40630747 -
Shock
A network pharmacology-based treatment analysis of luteolin for regulating pyroptosis in acute lung injury. [Abstract]2023 Aug 1;60(2):306-314. PMID: 37379125 -
Int J Biochem Cell Biol
Luteolin prevents hyperoxaluria-induced renal injury by inhibiting crystal deposition and renal inflammation. [Abstract]2026 May:194:106909. PMID: 41672398 -
Vet Microbiol
The Chinese medicine monomer Schisandrin C inhibits PRRSV infection by regulating the OGT-PI3K/AKT/mTOR signaling pathway. [Abstract]2026 May:316:110992. PMID: 41865607 -
BMC Pharmacol Toxicol
Effect of luteolin on oxidative stress and inflammation in the human osteoblast cell line hFOB1.19 in an inflammatory microenvironment. [Abstract]2024 Jul 12;25(1):40. PMID: 38997762 -
Vet Microbiol
Luteolin restricts ASFV replication by regulating the NF-κB/STAT3/ATF6 signaling pathway. [Abstract]2022 Oct:273:109527. PMID: 35961273 -
Toxicol In Vitro
Nonhomologous end joining and homologous recombination involved in luteolin-induced DNA damage in DT40 cells. [Abstract]2020 Jun;65:104825. PMID: 32169435 -
Pharm Dev Technol
Chylomicron-mimicking supramolecular nano emulsion for oral luteolin delivery against hyperuricemia. [Abstract]2025 Nov;30(10):1543-1556. PMID: 41255224 -
Biomed Res Int
Network-Based Pharmacology and Bioinformatics Study on the Mechanism of Action of Gujiansan in the Treatment of Steroid-Induced Avascular Necrosis of the Femoral Head. [Abstract]2022 Jul 23:2022:8080679. PMID: 35915795 -
Cancer Rep (Hoboken)
Unraveling the Anti-Tumor Effects and Molecular Mechanisms of Hairyvein Agrimonia Herb in Gastric Cancer Through Network Pharmacology and Experimental Validation. [Abstract]2025 May;8(5):e70169. PMID: 40391580 -
Biol Pharm Bull
He-Wei-Decoction Ameliorates Chronic Atrophic Gastritis via Modulation of the TLR4/NF-κB Signaling Pathway. [Abstract]2025;48(10):1514-1525. PMID: 41083380 -
Biol Pharm Bull
Regioselective Glucuronidation of Flavones at C5, C7, and C4' Positions in Human Liver and Intestinal Microsomes: Comparison among Apigenin, Acacetin, and Genkwanin. [Abstract]2022;45(8):1116-1123. PMID: 35908893 -
-
-
Int Ophthalmol
2025 Nov 19;45(1):494. PMID: 41258543 -
Medicine
Network pharmacology-based strategy for predicting therapy targets of Ecliptae Herba on breast cancer. [Abstract]2023 Oct 13;102(41):e35384. PMID: 37832105 -
Int J Clin Exp Pathol
Myocyte enhancer factor 2D promotes hepatocellular carcinoma through AMOTL2/YAP signaling that inhibited by luteolin. [Abstract]2022 May 15;15(5):206-214. PMID: 35698637 -
-
-
-
-
-
-
-
Oxid Med Cell Longev
JFD, a Novel Natural Inhibitor of Keap1 Alkylation, Suppresses Intracellular Mycobacterium Tuberculosis Growth through Keap1/Nrf2/SOD2-Mediated ROS Accumulation. [Abstract]2023 Feb 10:2023:6726654. PMID: 36819778 -
Contrast Media Mol Imaging
Luteolin Inhibited the Self-Renewal and Altered the Polarization of Primary Alveolar Macrophages. [Abstract]2022 Aug 18:2022:3517020. PMID: 36051934 -
Oxid Med Cell Longev
HO-1 Contributes to Luteolin-Triggered Ferroptosis in Clear Cell Renal Cell Carcinoma via Increasing the Labile Iron Pool and Promoting Lipid Peroxidation. [Abstract]2022 Apr 25;2022:3846217. PMID: 35656025 -
Evid Based Complement Alternat Med
Exploring the Antiglioma Mechanisms of Luteolin Based on Network Pharmacology and Experimental Verification. [Abstract]2021 Nov 27:2021:7765658. PMID: 34873410 -
Evid Based Complement Alternat Med
Identifying Active Compounds and Mechanism of Camellia nitidissima Chi on Anti-Colon Cancer by Network Pharmacology and Experimental Validation. [Abstract]2021 Aug 26:2021:7169211. PMID: 34484402
Pureté et documentation
-
Fiche technique (272 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Portuguese - PT (393 KB)
-
Instruction de manipulation (2659 KB)
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)